Industry Roundup: Nexium 24HR Tablet, Glanbia Deal, FDA Warnings
This article was originally published in The Tan Sheet
Executive Summary
FDA approves Nexium 24HR tablet; Glanbia grabs thinkThin; Nature’s Mojo spooks FDA; warning shadow on Seeds Of Light; Mobius crowd-funds for launch; doctors mum on probiotics for IBS; and more news in brief.